Stefan De Waele
Senior Investment Manager @ PMV
Brussels, Belgium
Stefan De Waele is a Series A investor at PMV in Brussels focused on Biopharma and Biotechnology. Stefan De Waele is the Senior Investment Manager at PMV. He attended KU Leuven.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Stefan De Waele invests in
Stages Stefan De Waele invests in
Countries Stefan De Waele invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biopharma 1 (100%)
- Biotechnology 1 (100%)
- Manufacturing 1 (100%)
- Pharmaceutical 1 (100%)
- Mechanical Engineering 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| RheaVita is a pharmaceutical company developing continuous freeze-drying technology for biopharmaceutical products. The company technology integrates all freeze-drying process step unit operations in a continuous production line with the constant infeed of products and the concomitant outfeed of the dried product. Its manufacturing approach avoidsscale-up issues, reduces cycle times, allows fast product development, reduces time-to-market, lowers production costs, makes use of smaller manufacturing installations, requires less clean room space, provides improved quality assurance (100% inspection with inherent potential for real-time-release) and leads to improved and uniform product quality and process uniformity. | $3.1M / Series A / Jun 02, 2021 |
Co-Investors
About PMV
PMV is a do and dare company that is shaping the future of the Flemish economy. It provides funding for promising companies' businesses, from the day they first open their doors, through their various growth stages and even on to operating internationally. Working with and for the government and other partners, PMV implements projects that are important for prosperity and well-being in Flanders. PMV is convinced that entrepreneurship is crucial for the development of a prosperous future for Flanders and everyone who lives there. It firmly believes that every promising enterprise project in Flanders needs to find funding – but also that every business needs to be profitable in order to be sustainable. Which is why PMV and the companies and projects in which it invests must be profitable in the end.
PMV Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Stefan De Waele
Senior Investment Manager
|
|||
Bart De Taeye
Investment Director
|
|||
Christine Claus
Director
|
|||
Clair Ysebaert
Director
|
|||
Diane Lejeune
Senior Investment Manager, Life Sciences and Care
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Stefan De Waele invest in?
Stefan De Waele invests primarily in Biopharma, Biotechnology and Manufacturing startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Stefan De Waele?
Public channels for Stefan De Waele include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Stefan De Waele last invest?
The most recent investment recorded for Stefan De Waele closed in Jun 2021. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
